Insider trading

Period: 120 months Stock: AMLX Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

21 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

21 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

21 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

21 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
21 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
21 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

21 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
15 Jan 2026
Cohen Joshua B Co-Chief Executive Officer
Sold at will
$1.85M 136,193 at 13.59
3.9%
Not planned
15 Jan 2026
Klee Justin B. Co-Chief Executive Officer
Sold at will
$1.85M 136,193 at 13.58
3.9%
Not planned
17 Apr 2023
Yeramian Patrick D Chief Medical Officer
Sold on a plan 2×
$1.51M 49,579 at 30.54
19.2%
Planned (10b5-1)
28 Mar 2023
Sold at will
$3.04M 100,000 at 30.37
1.4%
Not planned
27 Mar 2023
Sold at will 2×
$1.86M 60,964 at 30.50
0.8%
Not planned
21 Mar 2023
Sold at will 2×
$2.02M 63,448 at 31.91
0.9%
Not planned
16 Mar 2023
Cohen Joshua B Co-Chief Executive Officer
Sold at will 2×
$3.19M 100,000 at 31.86
3.5%
Not planned
16 Mar 2023
Klee Justin B. Co-Chief Executive Officer
Sold at will 2×
$3.19M 100,000 at 31.86
3.5%
Not planned
16 Mar 2023
Yeramian Patrick D Chief Medical Officer
Sold at will 2×
$1.74M 54,627 at 31.87
26.7%
Not planned
16 Mar 2023
Sold at will 2×
$1.12M 35,000 at 31.89
3.9%
Not planned
16 Mar 2023
FRATES JAMES M Chief Financial Officer
Sold at will 2×
$1.04M 32,500 at 31.89
95.6%
Sold half or more
15 Mar 2023
Sold, plan not stated 2×
$4.99M 150,000 at 33.27
2.0%
14 Mar 2023
Sold, plan not stated
$2.44M 70,714 at 34.54
0.9%
2 Mar 2023
Sold, plan not stated
$1.69M 50,000 at 33.75
0.7%
23 Feb 2023
Sold, plan not stated 2×
$1.78M 50,000 at 35.57
0.7%
22 Feb 2023
Sold, plan not stated 4×
$3.54M 100,000 at 35.36
1.3%
9 Sep 2022
VIKING GLOBAL INVESTORS LP 10% owner · indirect
Sold, plan not stated 6×
$21.16M 700,000 at 30.23
27.4%
8 Sep 2022
VIKING GLOBAL INVESTORS LP 10% owner · indirect
Sold, plan not stated 10×
$20.56M 700,000 at 29.37
25.2%
6 Jul 2022
ALS Invest 1 B.V. 10% owner
Sold, plan not stated 4×
$1.25M 60,609 at 20.70
1.0%
11 Jan 2022
VIKING GLOBAL INVESTORS LP 10% owner · indirect
Bought
$43.70M 2,300,000 at 19.00
opened
First buy on file
11 Jan 2022
Bought
$5.00M 263,158 at 19.00
2.5%
First buy on file
Showing 1–21 of 21.